Novel Therapies for the Treatment of Cystic Fibrosis: New Developments in Gene and Stem Cell Therapy

Clinics in Chest Medicine

Volumn 28, Issue 2, 2007, Pages 361-379

  Sueblinvong, Viranuj ^a   Suratt, Benjamin T ^a   Weiss, Daniel J ^a  

^a FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; PARVOVIRUS VECTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; VIRUS VECTOR;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYSTIC FIBROSIS; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

ANIMALS; CLINICAL TRIALS; CYSTIC FIBROSIS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; STEM CELL TRANSPLANTATION;

EID: 34247543054     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2007.02.004     Document Type: Review

References (146)

1. Riordan J.R., Rommens J.M., Kerem B.S., et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245 (1989) 1066-1073
2. Rommens J.M., Iannuzzxi M.C., Kerem B.S., et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245 (1989) 1059-1065
3. Collins F.S. Cystic fibrosis: molecular biology and therapeutic implications. Science 256 (1992) 774-779
4. Welsh M.J., and Smith A.E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73 (1993) 1251-1254
5. Mulligan R.C. The basic science of gene therapy. Science 260 (1993) 926-932
6. Rich D.P., Anderson M.P., Gregory R.J., et al. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 347 (1990) 358-363
7. Boucher R.C. Airway epithelial fluid transport. Am Rev Respir Dis 150 (1994) 271-281 581-93
8. Mehta A. CFTR: more than just a chloride channel. Pediatr Pulmonol 39 4 (2005) 292-298
9. Machen T.E. Innate immune response in CF airway epithelia: hyperinflammatory?. Am J Physiol Cell Physiology 291 2 (2006) C218-C230
10. Anson D.S., Smith G.J., and Parsons D.W. Gene therapy for cystic fibrosis airway disease: is clinical success imminent?. Curr Gene Ther 6 2 (2006) 161-179
11. Kreda S.M., Mall M., Mengos A., et al. Characterization of wild-type and delta F508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol Biol Cell 16 5 (2005) 2154-2167
12. Mall M., Grubb B.R., Harkema J.R., et al. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat Med 10 5 (2004) 487-493
13. Weiss D.J., and Pilewski J. Current status of gene therapy for cystic fibrosis. Seminars in Pulmonary and Critical Care Medicine 24 (2003) 749-770
14. Griesenbach U., Geddes D.M., and Alton E.W. Gene therapy progress and prospects: cystic fibrosis. Gene Ther 13 14 (2006) 1061-1067
15. Rosenecker J., Huth S., and Rudolph C. Gene therapy for cystic fibrosis lung disease: current status and future perspectives. Curr Opin Mol Ther 8 5 (2006) 439-445
16. Johnson L.G., Olsen J.C., Sarkadi B., et al. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet 2 (1992) 21-25
17. Johnson L.G., Boyles S.E., Wilson J., et al. Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells. J Clin Invest 95 (1995) 1377-1382
18. Hyde S.C., Gill D.R., Higgins C.F., et al. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 362 6417 (1993) 250-255
19. Ramalho A.S., Beck S., Meyer M., et al. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. Am J Respir Cell Mol Biol 27 (2002) 619-627
20. Oceandy D., McMorran B.J., Smith S.N., et al. Gene complementation of airway epithelium in the cystic fibrosis mouse is necessary and sufficient to correct the pathogen clearance and inflammatory abnormalities. Hum Mol Genet 11 (2002) 1059-1067
21. Kostyk A.G., Dahl K.M., Wynes M.W., et al. Regulation of macrophage chemokine expression by NaCl occurs independently of cystic fibrosis transmembrane conductance regulator. Am J Pathol 169 (2006) 12-20
22. Allard J.B., Poynter M.E., Marr K.A., et al. Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator. J Immunol 177 8 (2006) 5186-5194
23. Walters R.W., Grunst T., Bergelson J.M., et al. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J Biol Chem 274 (1999) 10219-10226
24. Wang G., Zabner J., Deering C., et al. Increasing epithelial junction permeability enhances gene transfer to mouse tracheal epithelium in vivo. Am J Respir Cell Mol Biol 22 (2000) 129-138
25. Pickles R.J., Fahrner J.A., Petrella J.M., et al. Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer. J Virol 74 (2000) 6050-6057
26. Kitson C., Angel B., Judd D., et al. The extra-and intercellular barriers to lipid and adenovirus-mediated pulmonary gene transfer to native sheep airway epithelium. Gene Therapy 6 (1998) 534-546
27. Perricone M.A., Rees D.D., Sacks C.R., et al. Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells. Hum Gene Ther 11 (2000) 1997-2008
28. Rooney C.P., Denning G.M., Davis B.P., et al. Bronchoalveolar fluid is not a major hindrance to virus-mediated gene therapy in cystic fibrosis. J Virol 76 20 (2002) 10437-10443
29. Haddad I.Y., Sorscher E.J., Garver J.I., et al. Modulation of adenovirus-mediated gene transfer by nitric oxide. Am J Respir Cell Mol Biol 16 (1997) 501-509
30. van Heeckeren A., Ferkol T., and Tosi M. Effects of bronchopulmonary inflammation induced by Pseudomonas aeruginosa on adenovirus-mediated gene transfer to airway epithelial cells in mice. Gene Therapy 5 (1998) 345-351
31. Worgall S., Leopold P.L., Wolff G., et al. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract. Hum Gene Ther 8 (1997) 1675-1684
32. Muruve D.A. The innate immune response to adenovirus vectors. Hum Gene Ther 15 12 (2004) 1157-1166
33. Whitsett J.A., Dey C.R., Stripp B.R., et al. Human cystic fibrosis transmembrane conductance regulator directed to respiratory epithelial cells of transgenic mice. Nat Genet 2 (1992) 13-20
34. Thorne P.S., McCray P.B., Howe T.S., et al. Early-onset inflammatory responses in vivo to adenoviral vectors in the presence or absence of lipopolysaccharide-induced inflammation. Am J Respir Cell Mol Biol 20 (1999) 1155-1164
35. Weiss D.J., Bonneau L., and Liggitt D. Use of perflourochemical liquid allows earlier detection and use of less adenovirus vector for gene expression in normal lung and enhances gene expression in acutely injured lung. Mol Ther 3 5 pt 1 (2001) 734-745
36. Morsy M.A., Gu M.C., Motzel S., et al. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Applied Biological Sciences 95 (1998) 7866-7871
37. Koehler D.R., Sajjan U., Chow Y.H., et al. Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia. Proc Natl Acad Sci U S A 100 26 (2003) 15364-15369
38. Koehler D.R., Martin B., Corey M., et al. Readministration of helper-dependent adenovirus to mouse lung. Gene Therapy 13 9 (2006) 773-780
39. Croyle M.A., Chirmule N., Zhang Y., et al. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J Virol 75 (2001) 4792-4801
40. Flotte T.R. Adeno-associated virus-based gene therapy for inherited disorders. Pediatr Res 58 6 (2005) 1143-1147
41. Virella-Lowell I., Poirier A., Chesnut K.A., et al. Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients. Gene Ther 7 (2000) 1783-1789
42. Duan D., Yue Y., Yan Z., et al. Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia. Hum Gene Ther 9 (1998) 2761-2776
43. Bals R., Xiao W., Sang N., et al. Transduction of well-differentiated airway epithelium by recombinant adeno-associated virus is limited by vector entry. J Virol 73 (1999) 6085-6088
44. Chao H., Liu Y., Rabinowitz J., et al. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther 2 (2000) 619-623
45. Summerford C., and Samulski R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J.Virol 72 (1998) 1438-1445
46. Summerford C., Bartlett J.S., and Samulski R.J. AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 5 (1999) 78-82
47. Walters R., Yi S.M., Keshavjee S., et al. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem 276 23 (2001) 20610-20616
48. Halbert C.L., Allen J.M., and Miller A.D. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J Virol 75 (2001) 6615-6624
49. Duan D., Yue Y., Yan Z., et al. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J Clin Invest 105 (2000) 1573-1587
50. Yan Z., Zak R., Luxton G.W., et al. Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. J Virol 76 (2002) 2043-2053
51. Sanlioglu S., and Engelhardt J.F. Cellular redox state alters recombinant adeno-associated virus transduction through tyrosine phosphatase pathways. Gene Ther 6 (1991) 1427-1437
52. Halbert C.L., Allen J.M., and Miller A.D. Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Nat Biotechnol 20 (2002) 697-701
53. Ostedgaard L.S., Zabner J., Vermeer D.W., et al. CFTR with a partially deleted R domain corrects the cystic fibrosis chloride transport defect in human airway epithelia in vitro and in mouse nasal mucosa in vivo. Proc Natl Acad Sci U S A 99 (2002) 3093-3098
54. Aitken M.L., Moss R.B., Waltz D.A., et al. A phase 1 study of aerosolized administration of tgAAVCF to cystic fibrosis patients with mild lung disease. Hum Gene Ther 12 (2001) 1907-1916
55. Flotte T.R., Zeitlin P.L., Reynolds T.C., et al. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Hum Gene Ther 14 11 (2003) 1079-1088
56. Moss R.B., Rodman D., Spencer L.T., et al. Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. Chest 125 2 (2004) 509-521
57. Flotte T.R., Schwiebert E.M., Zeitlin P.L., et al. Correlation between DNA transfer and cystic fibrosis airway epithelial cell correction after recombinant adeno-associated virus serotype 2 gene therapy. Hum Gene Ther 16 8 (2005) 921-928
58. Halbert C.L., Miller A.D., McNamara S., et al. Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors. Hum Gene Ther 17 4 (2006) 440-447
59. McCray P.B., Wang G., Kline J.N., et al. Alveolar macrophages inhibit retrovirus-mediated gene transfer to airway epithelia. Hum Gene Ther 8 (1997) 1087-1093
60. Wang G., Davidson B.L., Melchert P., et al. Influence of cell polarity on retrovirus-mediated gene transfer to differentiated human airway epithelial epithelia. J Virol 72 (1998) 9818-9826
61. Engelhardt J.F., Yankaskas J.R., and Wilson J.M. In vivo retroviral gene transfer into human bronchial epithelia of xenografts. J Clin Invest 90 (1992) 2598-2607
62. Halbert C.L., Aitken M.L., and Miller A.D. Retroviral vectors efficiently transduce basal and secretory airway epithelial cells in vitro resulting in persistent gene expression in organotypic culture. Hum Gene Ther 7 (1996) 1871-1881
63. Johnson L.G., Mewshaw J.P., Ni H., et al. Effect of host modification and age on airway epithelial gene transfer mediated by a murine leukemia virus-derived vector. J Virol 72 (1998) 8861-8872
64. Copreni E., Penzo M., Carrabino S., et al. Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis. Gene Ther 11 Suppl 1 (2004) S67-S75
65. Hacein-Bey-Abina S., von Kalle C., Schmidt M., et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348 (2003) 255-256
66. Slepushkin V.A., Staber P.D., Wang G., et al. Infection of human airway epithelia with H1N1, H2N2, and H3N2 influenza a virus strains. Mol Ther 3 (2001) 395-402
67. Zhang L., Peeples M.E., Boucher R.C., et al. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 76 (2003) 5654-5666
68. Ferrari S., Griesenbach U., Shiraki-Iida T., et al. A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo. Gene Ther 11 22 (2004) 1659-1664
69. Alton E.W. United Kingdom Cystic Fibrosis Gene Therapy Consortium. Use of nonviral vectors for cystic fibrosis gene therapy. Proc Am Thorac Soc 1 4 (2004) 296-301
70. Simoes S., Filipe A., Faneca H., et al. Cationic liposomes for gene delivery. Expert Opin Drug Deliv 2 2 (2005) 237-254
71. Tsan M.F., Tsan G.L., and White J.E. Surfactant inhibits cationic liposome-mediated gene transfer. Hum Gene Ther 8 (1997) 817-825
72. Stern M., Caplen N.J., Browning J.E., et al. The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro. Gene Therapy 5 (1998) 91-98
73. Scheule R.K., St. George J.A., Bagley R.G., et al. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum Gene Ther 8 (1997) 689-707
74. Ruiz F.E., Clancy J.P., Perricone M.A., et al. A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum GeneTher 12 (2001) 751-761
75. Yew N.S., Wang K.X., Przybylska M., et al. Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes. Hum Gene Ther 10 (1999) 223-234
76. Yew N.S., Zhao H., Wu I.H., et al. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol Ther 1 (2000) 255-262
77. Densmore C.L. Polyethyleneimine-based gene therapy by inhalation. Expert Opin Biol Ther 3 7 (2003) 1083-1092
78. Weiss D.J. Delivery of gene transfer vectors to lung: obstacles and the role of adjunct techniques for airway administration. Mol Ther 6 (2002) 148-152
79. Cipolla D.C., Gonda I., Shak S., et al. Coarse spray delivery to a localized region of the pulmonary airways for gene therapy. Hum Gene Ther 11 (2000) 361-371
80. Sene C., Bout A., Imler J.L., et al. Aerosol-mediated delivery of recombinant adenovirus to the airways of nonhuman primates. Hum Gene Ther 6 (1995) 1587-1593
81. Beck S.E., Laube B.L., Barberena C.I., et al. Deposition and expression of aerosolized rAAV vectors in the lungs of Rhesus macaques. Mol Ther 6 (2002) 546-554
82. Stern M., Sorgi F., Hughes C., et al. The effects of jet nebulisation on cationic liposome-mediated gene transfer in vitro. Gene Ther 5 (1998) 583-593
83. Muir D.F.C. Particle deposition. The lung: scientific foundations, 1839-1843 (1991), Raven Press Ltd, New York
84. Stonebraker J.R., Wagner D., Lefensty R.W., et al. Glycocalyx restricts adenoviral vector access to apical receptors expressed on respiratory epithelium in vitro and in vivo: role for tethered mucins as barriers to lumenal infection. J Virol 78 24 (2004) 13755-13768
85. Ernst U., Ulrichskotter S., Schmalix W.A., et al. Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant. J Gene Med 1 (1999) 331-340
86. Jobe A.H., Ueda T., Whitsett J.A., et al. Surfactant enhances adenovirus-mediated gene expression in rabbit lungs. Gene Ther 3 (1996) 775-779
87. Arcasoy S.M., Latoche J., Gondor M., et al. MUC1 and other sialoglycoconjugates inhibit adenovirus-mediated gene transfer. Am J Respir Cell Mol Biol 17 (1997) 422-435
88. Shean M.K., Baskin G., Sullivan D., et al. Immunomodulation and adenoviral-mediated gene transfer to the lungs of non-human primates. Hum Gene Ther 11 (2000) 1047-1055
89. Halbert C.L., Standaert T.A., Wilson C.B., et al. Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J Virol 72 (1998) 9795-9805
90. Look D.C., and Brody S.L. Engineering viral vectors to subvert the airway defense response. Am J Respir Cell Mol Biol 20 (1999) 1103-1106
91. Fasbender A., Lee J.H., Walters R.W., et al. Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo. J Clin Invest 102 (1998) 184-193
92. Chu Q., St. George J.A., Lukason M., et al. EGTA enhancement of adenovirus-mediated gene transfer to mouse tracheal epithelium in vivo. Hum Gene Ther 12 (2001) 455-467
93. Parsons D.W., Grubb B.R., Johnson L.G., et al. Enhanced in vivo airway gene transfer via transient modification of host barrier properties with a surface-active agent. Hum Gene Ther 9 (1998) 2661-2672
94. Coyne C.B., Kelly M.M., Boucher R.C., et al. Enhanced epithelial gene transfer by modulation of tight junctions with sodium caprate. Am J Respir Cell Mol Biol 23 (2000) 602-609
95. Jiang C., Akita G.Y., Colledge W.H., et al. Increased contact time improves adenovirus-mediated CFTR gene transfer to nasal epithelium of CF mice. Hum Gene Ther 8 (1997) 671-680
96. Seiler M.P., Luner P., Moninger T.O., et al. Thixotropic solutions enhance viral-mediated gene transfer to airway epithelia. Am J Respir Cell Mol Biol 27 (2002) 133-140
97. Factor P., Mendez M., Mutlu G.M., et al. Acute hyperoxic lung injury does not impede adenoviral-mediated alveolar gene transfer. Am J Respir Crit Care Med 165 (2002) 521-526
98. Weiss D.J., Strandjord T.P., Liggitt D., et al. Perflubron enhances adenoviral-mediated gene expression in lungs of transgenic mice with chronic alveolar filling. Hum Gene Ther 10 (1999) 2287-2293
99. Weiss D.J., Beckett T., Bonneau L., et al. Transient increase in lung epithelial tight junction permeability: an additional mechanism for enhancement of lung transgene expression by perfluorochemical liquids. Mol Ther 8 (2003) 927-935
100. Weiss D.J., Bonneau L., and Liggitt D. Inhalation of nebulized perflubron enhances adenovirus mediated gene expression in lung epithelium. Mol Ther 5 (2003) S68
101. McLean J.W., Fox E.A., Baluk P., et al. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am J Physiol Heart Circ. Physiol 273 (1997) H387-H404
102. Huard J., Lochmuller H., Acsadi G., et al. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 2 (1995) 107-115
103. Hyde S.C., Southern K.W., Gileadi U., et al. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther 7 (2000) 1156-1165
104. Joseph P.M., O'Sullivan B.P., Lapey A., et al. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis: I. Methods, safety, and clinical implications. Hum Gene Ther 12 (2001) 1369-1382
105. Harvey B.G., Maroni J., O'Donoghue K.A., et al. Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. Hum Gene Ther 13 (2002) 15-63
106. Wagner J.A., Nepomuceno I.B., Messner A.H., et al. A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF used maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Hum Gene Ther 13 (2002) 1349-1359
107. Konstan M.W., Davis P.B., Wagener J.S., et al. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum Gene Ther 12 (2004) 1255-1269
108. Griesenbach U., and Boyd A.C. UK Cystic Fibrosis Gene Therapy Consortium. Pre-clinical and clinical endpoint assays for cystic fibrosis gene therapy. J Cyst Fibros 4 2 (2005) 89-100
109. Korbling M., and Estrov Z. Adult stem cells for tissue repair: a new therapeutic concept?. N Engl J Med 349 6 (2003) 570-582
110. Prockop D.J. Further proof of the plasticity of adult stem cells and their role in tissue repair. J Cell Biol 160 6 (2003) 807-809
111. Herzog E.L., Chai L., and Krause D.S. Plasticity of marrow-derived stem cells. Blood 102 10 (2003) 3483-3493
112. Weiss D.J., Berberich M.A., Borok Z., et al. National Heart Lung Blood Institute/Cystic Fibrosis Foundation Workshop Report adult stem cells, lung biology, and lung disease. Proc Am Thorac Soc 3 (2006) 193-207
113. Wagers A.J., Christensen J.L., and Weissman I.L. Cell fate determination from stem cells. Gene Ther 9 10 (2002) 606-612
114. Neuringer I.P., and Randell S.H. Lung stem cell update: promise and controversy. Monaldi Arch Chest Dis 65 1 (2006) 47-51
115. Wang X., Willenbring H., Akkari Y., et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422 (2003) 897-901
116. Camargo F.D., Green R., Capetanaki Y., et al. Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med 9 (2003) 1520-1527
117. Pickering S.J., Minger S.L., Patel M., et al. Generation of a human embryonic stem cell line encoding the cystic fibrosis mutation deltaF508, using preimplantation genetic diagnosis. Reprod Biomed Online 10 3 (2005) 390-397
118. Denham M., Cole T.J., and Mollard R. Embryonic stem cells form glandular structures and express surfactant protein C following culture with dissociated fetal respiratory tissue. Am J Physiol Lung Cell Mol Physiol 290 6 (2006) L1210-L1215
119. Mateizel I., De Temmerman N., Ullmann U., et al. Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod 21 2 (2006) 503-511
120. Coraux C., Nawrocki-Raby B., Hinnrasky J., et al. Embryonic stem cells generate airway epithelial tissue. Am J Respir Cell Mol Biol 32 2 (2005) 87-92
121. Brown J.K., Hogan B.L.M., Randell S.H., Stripp B., and Weiss D.J. Human Embryonic Stem Cell Research: an official ATS Research Policy Statement. Am J Respir Crit Care Med 173 (2006) 1-3
122. Wang G., Bunnell B.A., Painter R.G., et al. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc Natl Acad Sci U S A 102 1 (2005) 186-191
123. Suratt B.T., Cool C.D., Serls A.E., et al. Human pulmonary chimerism after hematopoietic stem cell transplantation. Am J Respir Crit Care Med 168 3 (2003) 318-322
124. Mattsson J., Jansson M., Wernerson A., et al. Lung epithelial cells and type II pneumocytes of donor origin after allogeneic hematopoietic stem cell transplantation. Transplantation 78 1 (2004) 154-157
125. Kleeberger W., Versmold A., Rothamel T., et al. Increased chimerism of bronchial and alveolar epithelium in human lung allografts undergoing chronic injury. Am J Pathol 162 5 (2004) 1487-1494
126. Spencer H., Rampling D., Aurora P., et al. Transbronchial biopsies provide longitudinal evidence for epithelial chimerism in children following sex mismatched lung transplantation. Thorax 60 1 (2005) 60-62
127. Trotman W., Beckett T., Goncz K.K., et al. Dual Y chromosome painting and in situ cell-specific immunofluorescence staining in lung tissue: an improved method of identifying donor marrow cells in lung following bone marrow transplantation. Histochem Cell Biol 121 1 (2004) 73-79
128. Chang J.C., Summer R., Sun X., et al. Evidence that bone marrow cells do not contribute to the alveolar epithelium. Am J Respir Cell Mol Biol 33 4 (2005) 335-342
129. Loi R., Beckett T., Goncz K.K., et al. Limited restoration of defective cystic fibrosis lung epithelium in vivo with adult marrow derived cells. Am J Resp Crit Care Med 173 (2006) 171-179
130. Bruscia E.M., Price J.E., Cheng E.C., et al. Assessment of cystic fibrosis transmembrane conductance regulator (CFTR) activity in CFTR-null mice after bone marrow transplantation. Proc Natl Acad Sci U S A 103 8 (2006) 2965-2970
131. Ishizawa K., Kubo H., Yamada M., et al. Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Lett 556 1-3 (2004) 249-252
132. Yamada M., Kubo H., Kobayashi S., et al. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol 172 2 (2004) 1266-1272
133. Ortiz L.A., Gambelli F., McBride C., et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100 14 (2003) 8407-8411
134. Gomperts B.N., Belperio J.A., Burdick M.D., et al. Circulating progenitor cells traffic via CXCR4/CXCL12 in response airway epithelial injury. J Immunol 176 (2006) 1916-1927
135. Epperly M.W., Guo H., Gretton J.E., et al. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol 29 2 (2003) 213-224
136. Hashimoto N., Jin H., Liu T., et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 113 2 (2004) 243-252
137. Schmidt M., Sun G., Stacey M.A., et al. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 171 1 (2003) 380-389
138. Gupta N., Su X., Serikov V., et al. Intrapulmonary administration of mesenchymal stem cells reduces LPS induced acute lung injury and mortality. Proc Am Thoracic Soc 3 (2006) A25
139. Reynolds S.D., Giangreco A., Power J.H., et al. Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am J Pathol 156 (2000) 269-278
140. Hong K.U., Reynolds S.D., Giangreco A., et al. Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am J Respir Cell Mol Biol 24 (2001) 671-681
141. Giangreco A., Reynolds S.D., and Stripp B.R. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol 161 (2002) 173-182
142. Schoch K.G., Lori A., Burns K.A., et al. A subset of mouse tracheal epithelial basal cells generates large colonies in vitro. Am J Physiol Lung Cell Mol Physiol 286 4 (2004) L631-L642
143. Engelhardt J.F., Schlossberg H., Yankaskas J.R., et al. Progenitor cells of the adult human airway involved in submucosal gland development. Development 121 (1995) 2031-2046
144. Zepeda M.L., Chinoy M.R., and Wilson J.M. Characterization of stem cells in human airway capable of reconstituting a fully differentiated bronchial epithelium. Somat Cell Mol Genet 21 (1995) 61-73
145. Hollande E., Cantet S., Ratovo G., et al. Growth of putative progenitors of type II pneumocytes in culture of human cystic fibrosis alveoli. Biol Cell 96 6 (2004) 429-441
146. Noone P.G., Hohneker K.W., Zhou Z., et al. Safety and biological efficacy of a lipid-CFTR complex for gene transfer in nasal epithelium of adults patients with cystic fibrosis. Mol Ther 1 1 (2000) 105-114